Previous Page  11 / 12 Next Page
Information
Show Menu
Previous Page 11 / 12 Next Page
Page Background

Harvey

is a 9 years old Labrador, with a mass on his lower jaw. A biopsy confirmed

this to be a cancerous tumour known as squamous cell carcinoma.

The tumour made it difficult

for him to eat, causing a lot

of drooling, bleeding when

rubbed, and developed a

bad smell due to secondary

infection. Almost certainly

it was also a source of

discomfort, which none

of us want for our pets

or patients.

Blood tests, ultrasonography

and radiographic imaging did

not find any evidence of the

tumour having spread to

other sites.

When dealing with cancers

surgically, we try to remove

a margin of cancer-free tissue

in all directions. This can

sometimes mean removal of

quite large areas of tissue.

Harvey underwent a

mandibulectomy procedure to

remove the front half of his

lower jaw. As well as opioid

and anti-inflammatory pain

relief we give these patients

nerve blocks, which last for

6 - 8 hours keeping them as

comfortable as possible in

recovery. Within 12 hours of

his operation, Harvey was

drinking water on his own, and

starting to eat 3 cm meat

balls, offered by hand. As

much as he enjoyed being

hand fed, he was able to eat

soft food, on his own, within

3 days.

Lower jaw prepared for surgery

Side profile after mandibulectomy

Reconstructed lower jaw after

tumour removal

Dogs tend to cope

incredibly well with

a mandibulectomy,

and unlike cats, rarely

require a feeding tube

in the recovery period.

Studies suggest that

91% of dogs with this

type of tumour should

survive more than 12

months with a range

of between 6 months

to 7 years.

Surgical removal of oral

tumours is usually the

treatment of choice and can

often be curative. Surgery is

sometimes, but not always,

used together with anti-cancer

medicines (chemotherapy).

Radiotherapy can also

sometimes be an option, but

availability can be difficult.

The owners wanted Harvey to

have surgery and naltrexone

medication, which is an

unproven drug, albeit seemingly

with minimal side effects,

suspected of slowing the

progression of cancers in man.